Login / Signup

Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?

Neil D GrossTanguy Y Seiwert
Published in: Cancer (2024)
Keyphrases